Shares of Biohaven Ltd. (NYSE: BHVN) climbed 7% as the company announced the FDA's acceptance and Priority Review of its ...
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Biohaven Ltd. (BHVN – Research Report), ...
News of a big and important regulator's move was the electricity that powered Biohaven (NYSE: BHVN) stock to an 11%-plus gain on the second trading day of the week. Its leading investigational drug is ...
Biohaven (BHVN) is jumping 10% after the FDA ... If you are looking for an AI stock that is more promising than BHVN but that trades at less than 5 times its earnings, check out our report about ...
Sustainalytics’ Controversies Research identifies companies involved in incidents and events that may negatively impact stakeholders, the environment or the company’s operations. Controversies ...
Biohaven Ltd. (NYSE:BHVN – Get Free Report)’s stock price gapped down prior to trading on Friday . The stock had previously closed at $39.17, but opened at $36.98. Biohaven shares last traded ...
The last time I wrote about Biohaven (NYSE:BHVN ... one catalyst that could have a significant impact on the stock price for sure, but there are actually a few other catalysts that are expected ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Deutsche Bank analyst David Hoang initiated coverage on Biohaven with a Buy rating and a price target of $65.00 ... The company's stock movement reflects investor confidence in its strategic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results